Dr Nabil Elmahdawi

Dr Nabil Elmahdawi, MBChB, MD, MRCP(UK), FRCR, AMRCOG. Head of service of Clinical Oncology in the Queen’s Centre, Hull, UK. Medical Director and Cofounder of eJoli Clinic, Specialised Medical Aesthetic Clinic, Beverley UK.

Nabil Elmahdawi is Senior Consultant in Clinical Oncology, he has started is NHS medical career in 1997, has led an outstanding service to the British community and contributed positively to the running of its service in emergency and General and acute Medicine and Last but not the least in Oncology where he is the Head of service of clinical oncology, Radiation oncologist and brachytherapist. Also he developed an interest in medical aesthetics especially combined  treatment modality, he is a cofounder and the medical director of eJoli clinic in Yorkshire and the medical Director of the women’s clinic in Glascow. He developed passion to the female cancer survivors menopause and valvovaginal atropy as a result of cancer treatment.

Nabil Elmahdawi, he is trainer and safety educator in this field and has received global and awards and commendation throughout his oncology and cancer menopause career. His high expertise in gynaecology oncology and regenerative  medicine has led to his development in the functional and aesthetic improvement in women cancer survivors and cancer survivors to compact the aging process of this gruelling illness.

Choose A Blog

Browse Our Menopause Blogs By Dr Nabil Elmahdawi

Blog

Vulvovaginal Atrophy after Cancer Treatment

Vulvovaginal atrophy (VVA) is a common side effect of cancer treatments like chemotherapy, radiation, and hormone therapy, causing dryness, discomfort, and pain. Various hormonal and non-hormonal treatments can help manage and relieve symptoms."

Read More
Blog

Menopause and Cancer

Menopause in cancer survivors is often triggered by treatments like chemo, radiation, or surgery, causing early symptoms. It impacts physical, emotional, and sexual health, requiring personalized care, non-hormonal therapies, and survivorship support."

Read More